-
Biomimetic Chromatography for Pulmonary Permeability
2026-08-24
A 2024 Journal of Chromatography A study directly compared immobilised artificial membrane liquid chromatography with liposome electrokinetic capillary chromatography for drug–membrane partitioning and pulmonary permeability assessment. The findings indicate that LEKC more closely models apparent lung permeability, whereas IAM LC offers broader compound coverage, simpler operation, and stronger suitability for automated screening.
-
Targeted EPO mRNA Nanotherapy for Spinal Cord Injury
2026-08-23
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia in injured spinal cord. In mice, localized EPO production reduced neuroinflammation and ferroptosis-associated damage while improving axonal preservation and motor recovery, supporting targeted mRNA delivery as a strategy for secondary spinal cord injury repair.
-
Disulfide-Aware Surface Biotinylation for Translation
2026-08-22
Surface biotinylation is most powerful when it is interpreted alongside protein folding, trafficking, and extracellular disulfide biology. This thought-leadership guide positions Sulfo-NHS-SS-Biotin as a reversible tool for studying membrane-protein abundance and purification while clarifying what the chemistry can—and cannot—reveal about transporter structure and function.
-
Arachidonic Acid Supplementation and Humoral Immunity
2026-08-22
The reference study identifies dietary arachidonic acid as a potential nutritional adjuvant that accelerates rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is to connect lymph-node arachidonic acid metabolism with prostaglandin I2, cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.
-
Z-DEVD-FMK: Caspase-3 Inhibition in Apoptosis
2026-08-21
Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor used to test executioner-caspase involvement in apoptosis assays. Product documentation also describes calpain inhibition and experimental neuroprotection after traumatic brain injury or cerebral ischemia.
-
Estradiol Benzoate: From Binding to Better Assays
2026-08-20
Estradiol Benzoate is an estrogen receptor alpha agonist for dissecting receptor occupancy, signaling, and assay performance. This guide pairs receptor pharmacology with a structure-based screening study to build a more rigorous, orthogonal workflow for hormone receptor research.
-
Cefotaxime for Reproducible Resistance Assays
2026-08-20
Cefotaxime (SKU BA1012) supports controlled antimicrobial resistance research and bacterial infection model workflows where antibiotic handling, isolate variability, and cell-based readouts can compromise interpretation. This scenario-driven guide connects formulation, storage, experimental controls, and recent carbapenemase-transmission evidence to practical laboratory decisions.
-
Pheromone-Driven Neurodegeneration in C. elegans
2026-08-19
Peng et al. show that pheromone exposure during the L1 developmental stage can remodel neural circuitry and accelerate adult neurodegeneration in C. elegans. Their work identifies coordinated ASK–ASI signaling through AIA interneurons, insulin-like signaling, and autophagy inhibition as a mechanistic link between early chemical experience and later proteostasis failure.
-
mCherry mRNA as an LNP Delivery Assay Control
2026-08-19
mCherry mRNA can serve as more than a fluorescent reporter: it is a functional control for evaluating LNP-mediated RNA delivery before costly gene-editing studies. This article explains how Cap 1, modified nucleotides, and poly(A) design support interpretable fluorescent protein expression.
-
SM-102 for Smarter mRNA Delivery
2026-08-18
SM-102 provides a chemically defined ionizable-lipid starting point for mRNA delivery, from vaccine formulation screens to mechanistic cellular assays. Its strongest use is not as a universal winner, but as a reproducible comparator within data-driven lipid nanoparticle optimization.
-
EdU Flow Cytometry Assay Kits (Cy5): Practical Guide
2026-08-18
EdU Flow Cytometry Assay Kits (Cy5) support quantitative measurement of DNA synthesis during S phase without the harsh DNA denaturation used in many BrdU workflows. This guide covers setup, controls, gating, and troubleshooting; the assay should be used to measure labeled DNA synthesis during a defined pulse, not as a standalone proof of total cell proliferation or complete cell-cycle progression.
-
Prevotella copri, IPA Depletion, and Breast Cancer
2026-08-17
The reference study links Prevotella copri enrichment with breast cancer progression through depletion of host indole-3-pyruvic acid, a tryptophan-derived metabolite. Its integrated microbiome, metabolite, animal, and molecular analyses connect reduced IPA availability with UHRF1-mediated suppression of AMPK signaling, while also defining important limits for translation beyond preclinical models.
-
Hexamethonium Bromide for Reliable Cell Assays
2026-08-17
Learn how Hexamethonium Bromide, SKU B1592, can support mechanistic studies of neuronal nicotinic acetylcholine receptor signaling while reducing ambiguity in cell viability and cytotoxicity workflows. This scenario-based guide connects product specifications with autonomic physiology evidence and practical assay controls.
-
Metal-Ion Enrichment Improves mRNA Vaccine Design
2026-08-16
The reference study introduces a manganese-mediated strategy for concentrating mRNA into a dense core before lipid coating, nearly doubling loading capacity and improving cellular uptake compared with conventional LNP-mRNA formulations. Its findings suggest that controlling nanoparticle architecture, rather than modifying only lipid composition or RNA sequence, can support dose-sparing vaccine design while reducing anti-PEG immune responses.
-
TPPU: A Soluble Epoxide Hydrolase Inhibitor
2026-08-15
TPPU is a potent soluble epoxide hydrolase inhibitor with nanomolar activity against human and mouse sEH. Product and preclinical evidence supports its use for studying fatty acid epoxide signaling, inflammatory pain, and sEH-linked redox mechanisms, but it remains a research-use compound rather than a clinical treatment.